HWPC(SH:688799) Xin Lang Cai Jing·2025-09-01 03:18Group 1 - Warner Pharmaceutical's stock increased by 5.02%, reaching 53.93 CNY per share, with a trading volume of 199 million CNY and a turnover rate of 2.88%, resulting in a total market capitalization of 7.082 billion CNY [1] - The company, founded on April 30, 2001, and listed on July 13, 2021, is based in Changsha, Hunan Province, and specializes in the research, production, and sales of chemical raw materials, chemical drug formulations, and traditional Chinese medicine formulations [1] - The revenue composition of Warner Pharmaceutical includes 74.47% from formulations, 24.46% from raw materials and intermediates, 0.99% from other sources, and 0.08% from plant extracts and food [1] Group 2 - Jinxin Fund holds a significant position in Warner Pharmaceutical, with its Jin Xin Value Selected Mixed A Fund (005117) owning 41,000 shares, accounting for 4.25% of the fund's net value, making it the seventh-largest holding [2] - The Jin Xin Value Selected Mixed A Fund has achieved a year-to-date return of 70.97%, ranking 212 out of 8,254 in its category, and a one-year return of 112.38%, ranking 252 out of 8,037 [2] - The fund managers, Liu Shang, Zhao Haoran, and Tan Zhiwei, have varying tenures and performance records, with Zhao Haoran achieving the best return of 49.65% during his tenure [2]